A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TB-840 in Healthy Subjects

Clinical trial NCT05045534 · COMPLETED

Trial details

NCT number: NCT05045534
Sponsor: Therasid Bioscience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-09-14
Primary completion: 2022-08-29
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.